Colgate-Palmolive Company (CL) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Net sales rose 8.4% year-over-year to $5,324 million in Q1 2026, with organic sales up 2.9% and strong growth in emerging markets, especially Asia-Pacific and Latin America, despite a 0.6% drag from the exit of private label pet food.
Adjusted EPS increased 7% to $0.97, while GAAP EPS declined 6% to $0.80 due to $176 million in pre-tax charges from the expanded Strategic Growth and Productivity Program.
Free cash flow rose 28% year-over-year to $747 million, with working capital improvements and record cash generation.
Investments in advertising, innovation, digital, and AI are driving brand strength, market share gains, and long-term strategy.
The company completed the acquisition of Prime 100, expanding its pet nutrition segment in Australia.
Financial highlights
Gross profit increased to $3,226 million, but gross margin slipped to 60.6% from 60.8% due to higher raw and packaging material costs.
Operating profit (GAAP) fell 10% to $964 million, while Base Business operating profit rose 4% to $1,134 million; operating profit margin dropped to 18.1% (GAAP), with adjusted margin at 21.3%.
Free cash flow before dividends increased to $609 million from $476 million year-over-year.
Advertising spending increased to $734 million from $668 million year-over-year.
Hill’s Pet Nutrition delivered 4.8% organic growth (ex-private label), with strong performance in Science Diet and Prescription Diet.
Outlook and guidance
Full-year 2026 net sales expected to grow 2%–6%, with organic sales growth guidance at 1%–4% and a low-single-digit FX benefit.
Gross profit margin now expected to decline for the year due to $300 million in additional raw material and logistics costs, assuming oil at $110/barrel.
Double-digit GAAP EPS growth and low-to-mid single-digit Base Business EPS growth anticipated.
Advertising spend to increase as a percentage of net sales and in absolute terms.
Flexibility in cost savings, productivity, and potential incremental pricing to offset inflationary pressures.
Latest events from Colgate-Palmolive Company
- Director elections, auditor ratification, and key shareholder proposals headline the annual meeting.CL
Proxy filing16 Apr 2026 - Board recommends supporting company proposals, highlights strong governance, and opposes two shareholder proposals.CL
Proxy filing25 Mar 2026 - Board recommends voting for all directors and auditor, against DEI removal and independent chair.CL
Proxy filing25 Mar 2026 - 2030 strategy targets growth through premium innovation, digital scale, and agile execution.CL
UBS Global Consumer and Retail Conference11 Mar 2026 - 2030 strategy leverages innovation, AI, and omni-channel execution to drive global growth and ROI.CL
Consumer Analyst Group of New York Conference (CAGNY) 202620 Feb 2026 - Premiumization, innovation, and digital transformation drive growth amid global volatility.CL
2025 dbAccess Global Consumer Conference3 Feb 2026 - Q2 2024 saw 4.9% sales growth, margin expansion, and upgraded full-year guidance.CL
Q2 20242 Feb 2026 - 2025 sales rose 1.4% with record cash flow; 2026 outlook targets higher EPS and innovation.CL
Q4 20252 Feb 2026 - Balanced growth and innovation drive market share and margin gains across regions and categories.CL
4th Annual Evercore ISI Consumer and Retail Conference1 Feb 2026